CS logo
small CS logo
Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center

Seoul, Korea, Republic of

About Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center


During the past decade, Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center" #1 collaborator was "Baxter Healthcare Corporation" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Korean Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center


According to Clinical.Site data, the most researched conditions in "Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center" are "Cervical Cancer" (4 trials), "Endometrial Cancer" (3 trials), "Benign Ovarian Tumor" (1 trials), "Benign Uterine Disease" (1 trials) and "Benign or Preinvasive Uterine Disease" (1 trials). Many other conditions were trialed in "Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center


Most popular intervention types in "Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center" are "Procedure" (5 trials), "Drug" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "FloSeal application" (2 trials), "Electrocautery" (1 trials), "Farlutal tab. 500mg/ Pfizer" (1 trials), "Four-port laparoscopic surgical staging" (1 trials) and "Nerve sparing radical hysterectomy" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center


The vast majority of trials in "Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center" are 10 trials for "Female" genders.

Clinical Trials Status at Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center


Currently, there are NaN active trials in "Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".